Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant

Clinical trial NCT00228176 · TERMINATED

Trial details

NCT number: NCT00228176
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carotid Artery Plaque Arteriosclerosis Obesity Metabolic Syndrome X

Start date: 2005-08-01
Primary completion: 2009-04-01
Enrollment: 661

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.